TOMM40 association with Alzheimer disease: Tales of APOE and linkage disequilibrium

Archives of Neurology

Volumn 69, Issue 10, 2012, Pages 1243-1244

  Guerreiro, Rita J ^a   Hardy, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; MEMBRANE PROTEIN; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOE GENE; CHROMOSOME 19; EDITORIAL; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE; TRANSCRIPTION REGULATION;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84867386549     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.1935     Document Type: Editorial

References (20)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977-1981. (Pubitemid 23069980)
2. Coon KD, Myers AJ, Craig DW, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68(4):613-618. (Pubitemid 46663046)
3. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3(4):569-574.
4. Schellenberg GD, Deeb SS, Boehnke M, et al. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet. 1987;4(2-3): 97-108. (Pubitemid 17050015)
5. Roses AD, Lutz MW, Amrine-Madsen H, et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J. 2010; 10(5):375-384.
6. Humphries AD, Streimann IC, Stojanovski D, et al. Dissection of the mitochondrial import and assembly pathway for human Tom40. J Biol Chem. 2005;280(12): 11535-11543. (Pubitemid 40418465)
7. Mager F, Gessmann D, Nussberger S, Zeth K. Functional refolding and characterization of two Tom40 isoforms from human mitochondria. J Membr Biol. 2011; 242(1):11-21.
8. Moreira PI, Santos MS, Oliveira CR. Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid Redox Signal. 2007;9(10):1621-1630. (Pubitemid 47462966)
9. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39(1):17-23. (Pubitemid 46026496)
10. Bruno D, Nierenberg JJ, Ritchie JC, Lutz MW, Pomara N. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants. Psychoneuroendocrinology. 2012;37(3):366-371.
11. Chu SH, Roeder K, Ferrell RE, et al. TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease. Neurobiol Aging. 2011;32(12):2328-2329, e1-e9.
12. Cruchaga C, Nowotny P, Kauwe JS, et al. Alzheimer's Disease Neuroimaging Initiative. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol. 2011;68(8):1013-1019.
13. Johnson SC, La Rue A, Hermann BP, et al. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype. Alzheimers Dement. 2011;7(4):456-465.
14. Pomara N, Bruno D, Nierenberg JJ, et al. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly. Neurochem Res. 2011;36(6):1124-1128.
15. Yu CE, Seltman H, Peskind ER, et al. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics. 2007;89(6):655-665. (Pubitemid 46719797)
16. Jun G, Vardarajan BN, Buros J, et al; the Alzheimer's Disease Genetics Consortium. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region [published online August 6, 2012]. Arch Neurol. 2012;69(10):1270-1279.
17. Lambert JC, Pérez-Tur J, Dupire MJ, et al. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet. 1997;6(12):2151-2154.
18. Bekris LM, Lutz F, Yu CE. Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. J Hum Genet. 2012;57(1):18-25.
19. Lutz MW, Crenshaw DG, Saunders AM, Roses AD. Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement. 2010;6(2):125-131.
20. Roses AD. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Arch Neurol. 2010;67(5):536-541.